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Abstract

➢ While many hand infections are superficial,
diligent evaluation, diagnosis, and treatment
of these infections are central for preventing
disability and morbidity.
➢ Maintaining a wide differential diagnosis is
important as some hand infections may
mimic others.
➢ In geographic areas with more than a 10% to
15% prevalence of community-acquired
methicillin-resistant Staphylococcus aureus
(MRSA) hand infections, empiric antibiotics
should adequately cover MRSA.
➢ Once culture results are available, antibiotic
regimens should be narrowed to reduce the
development of resistant pathogens.
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Infections of the hand and fingers are
common and benefit from prompt evaluation. While
many infections may be self-limited and superficial,
timely and effective treatment can prevent disability
and morbidity, including loss of function,
deformity, and the need for amputation/salvage
procedures1-9. Effective treatment requires accurate
diagnosis, appropriate antibiotics, and potential
surgical intervention. The purpose of this article is
to review the recent literature regarding the
management of hand infections.
Microbiology

Skin flora are the most common causative
agents of hand infections (Table I), specifically
Staphylococcus and Streptococcus species3,8,10-13.
The majority of the Staphylococcus species
infections are caused by methicillin-sensitive
Staphylococcus aureus (MSSA); however, the
prevalence of methicillin-resistant S. aureus
(MRSA)12-15 is growing. Over the past decade,
empiric antibiotic treatment strategies have been
adjusted to accommodate for evolving microbial
resistance patterns. Although Kistler et al.14
identified a decreasing trend of MRSA hand
infections at an urban academic center, the overall
rate of MRSA hand infections remained high at
47% to 52%12,13. Tosti et al.13 identified increasing
multidrug resistance patterns among hand infections
over a 7-year period (2005 to 2012). It is important
to be aware of the local flora and resistance patterns
in order to appropriately treat hand infections11,15-20.
Antibiotic Therapy

Table I provides recommendations for
empiric antibiotic therapy for the various hand
infections that are discussed below. The regimen
should be adjusted as the specific pathogens are
identified, in order to reduce the development of
resistant pathogens and more effectively treat the
specific pathogen. Traditionally, first-generation
cephalosporins have been recommended for empiric
antibiotic treatment. However, the Centers for
Disease Control and Prevention recommend that in
geographic regions where the prevalence of
community-acquired MRSA infections is more than
10% to 15%21 (most urban and suburban regions),
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antibiotics that cover MRSA should be the first-line
empiric treatment (e.g.,
trimethoprim/sulfamethoxazole, clindamycin, and
doxycycline). For inpatients, intravenous
vancomycin and clindamycin remain the drugs of
choice22,23; however, recent publications report an
increased prevalence of clindamycin-resistant
MRSA (7% in 2005 and 20% in 2012)10,13,23,24.
Patient Factors

Patient factors that should be considered
when managing hand infections are
immunosuppression and intravenous drug use
(IVDU). Immunosuppression predisposes patients
to infection. The etiology of the suppressed state
may vary with different conditions (e.g., human
immunodeficiency virus (HIV)/acquired
immunodeficiency syndrome (AIDS), diabetes
mellitus (DM), or rheumatologic conditions, and in
patients who use immunomodulating medications).
While immunocompromised patients are more
likely to become infected with common pathogens
than immunocompetent individuals, they are also at
an increased risk of opportunistic and nosocomial
infections2,3,8,10,11,15-18,25. Additionally, they are
more likely to have complications and may require
more rounds of treatment compared with
immunocompetent individuals2,3,8,10,11,15-18,25.
IVDU is linked to a higher rate of infections
due to direct seeding of tissues (nonsterile injection
practices or contaminated drugs), risk of
HIV/AIDS, and riskier behaviors (sexual behaviors,
poor hygiene, tissue trauma, or malnutrition)26,27.
These infections are primarily due to S. aureus and
polymicrobial infections3,8,10,11,15-18,26,27. The
increasing rates of MRSA must be accounted for
when treating hand infections that are linked to
IVDU because these patients are more likely to
have positive cultures after successful incision and
drainage10. IV drug abusers are also at a higher risk
of nosocomial infections, necrotizing fasciitis, and
gram-negative infections2,3,8,10,11,15-18,26,27.
Paronychia

Paronychia is the most common infection of
the hand. It is an infection of the nail fold that is
precipitated by a disruption of the seal between the
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nail plate and the paronychium/eponychium10,28.
Paronychia may present acutely (for <6 weeks) or
chronically (for >6 weeks). The most common
causes include nail injuries, onychophagia,
manicures, and finger and/or thumb-sucking. The
etiologies and treatments vary between acute and
chronic paronychia.
Acute Paronychia
An acute paronychia typically presents with
a painful erythematous nail fold, with possible
fluctuance around the nail. The most common
pathogens for acute paronychia are Staphylococcus,
Streptococcus, Enterococcus, and Pseudomonas
species29. Patients with an acute paronychia
typically present with acute painful erythematous
inflammation of the nail fold on a single digit30
(Fig. 1). Abscesses may form and disrupt the nail
plate, causing elevation and onycholysis. Because
the diagnosis is clinical, laboratory tests and
imaging are not necessary28,30. Patient history
should help rule out potential atypical organisms,
such as herpes virus (see the section below on
herpetic whitlow) and anaerobes (oral exposure) or
gram-negative organisms (exposure to animals)30.
The management plan for acute paronychia
depends on the extent of symptoms and/or the
presence of an abscess. Early presentations with
minimal to mild symptoms and without an abscess
or cellulitis should be treated nonsurgically, which
consists of empiric antibiotics (Table I) and
frequent warm soaks28,30. Adding Burow’s solution
(aluminum acetate solution) and vinegar (acetic
acid) to the warm soaks may have beneficial
antimicrobial effects28,31. Topical corticosteroids are
effective at managing symptoms with minimal to no
side effects32. The presence of an abscess, extensive
involvement of the eponychium, or unsuccessful
nonsurgical management are indications for surgical
management28,30.
Chronic Paronychia
Chronic paronychia refers to inflammation
without fluctuance or abscess formation of the
paronychium/eponychium that lasts for >6 weeks.
Risk factors include repetitive exposure to irritants
such as acids, alkali, and other chemicals, causing
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chronic inflammation that may precipitate
colonization by bacterial or fungal pathogens (most
commonly Candida albicans)28-30. Housekeepers,
cooks, dishwashers, bartenders, laundry workers,
and swimmers are at greater occupational risk of
chronic paronychia28-30.
The initial step in management is to avoid
irritants, moisture, and additional damage to the
paronychium/eponychium (e.g., manicures or
onychophagia)28-30. Medical management begins
with controlling inflammation with topical
corticosteroids, calcineurin inhibitors, antiinflammatory medications, or antifungals28,33 (Table
I). Rigopoulos et al. found that 0.1% tacrolimus was
more effective than 0.1% betamethasone in treating
chronic paronychia34. Okano et al.35 and Merritt36
demonstrated that gentian violet dye (antiseptic and
antifungal) also was effective at treating chronic
paronychia. Associated bacterial infections can be
managed with oral antibiotics (Table I). Systemic
corticosteroids or antifungal agents are not
necessary unless patients present with refractory
disease or multidigit involvement28,30. For refractory
cases, surgical intervention in the form of
eponychial marsupialization, or nail excision
without matrix ablation for cases with nail damage,
may be indicated29,30,37.
Felon

A felon is a closed space infection of the
pulp of the fingertip. Like a paronychia, it can be
very painful, but unlike a paronychia it can advance
quickly and generally does not involve the nail
folds4,6,38. Typically, a felon develops after
disruption of the skin barrier (e.g., fingertip glucose
testing) and subsequent colonization4,5,38. Common
pathogens are S. aureus followed by other
Staphylococcus or Streptococcus species5. Felons
may eventually spread, resulting in osteomyelitis of
the distal aspect of the phalanx or septic flexor
tenosynovitis4.
A felon is characterized by an acute onset of
localized pain, erythema, swelling, and/or
fluctuance of the distal digital pulp5,6. The pain is
typically due to the buildup of pressure in the closed
compartments of the digit4,5. Early presentations
without abscess formation can be adequately treated
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with antibiotics (Table I), warm soaks, elevation,
and observation4,5,38. However, in the setting of
fluctuance or an abscess, surgical drainage is
indicated4-6,38. Typically, the incision is placed at
the site of the greatest fluctuance. Whenever
possible, a mid-lateral approach is recommended.
Similarly, a radial-sided approach to the thumb and
an ulnar-sided approach to the fingers are
recommended to avoid incisions at the sites of key
pinch. A “fish-mouth” incision is best avoided to
prevent devascularization of the pulp and the skin.
After the incision has been made, it is essential to
take down all of the septa to adequately decompress
and drain the pulp/compartment4-6. Following
incision, drainage, taking of culture specimens,
debridement of devitalized tissue, and thorough
irrigation, the wound can be loosely closed or left
open. Soaks can be initiated postoperatively, and
empiric antibiotics should be administered (Table I)
until wound culture specimens specify the pathogen
and culture-specific antibiotics can be initiated4,5,38.
Herpetic Whitlow

Herpetic whitlow is a fingertip infection that
is caused by the herpes simplex virus (HSV-1 or
HSV-2). It is commonly mistaken for a felon or
paronychia. The infection presents most commonly
in a bimodal distribution in both children (<10 years
old) and young adults (20 to 30 years old). It is
spread via direct contact of infected bodily fluids
and mucous membranes (including self-inoculation)
with previously disrupted/irritated skin, making
nail-biters, thumb-suckers, and dental professionals
at highest risk39,40. Herpetic whitlow classically
presents on the digital pulp as a single vesicle or a
cluster of vesicles39,40. Vesicles are typically painful
and have an area of central pallor on an
erythematous base39,41. The lesions typically present
1 to 2 weeks after inoculation (which coincides with
the window of viral shedding)39,40. Before the
formation of the vesicles, patients may experience a
flulike prodrome, consisting of fever and regional
lymphadenitis39,40. Vesicles may coalesce and
mimic another infection and/or abscess of the digit.
Serologic studies are not used in the diagnosis of
herpetic whitlow; however, a positive Tzanck test
(specific for HSV and herpes zoster), viral culture,
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or polymerase chain reaction (PCR) study may be
used to confirm the presence of HSV40. Herpetic
whitlow in immunocompetent individuals is
generally self-limited and resolves spontaneously
within 3 weeks39,41. With recurrent or recalcitrant
infections, acyclovir has been shown to be
beneficial. Acyclovir is indicated for all
immunocompromised patients who present with
HSV, regardless of whether it is localized or
disseminated39,40. Surgical treatment of herpetic
whitlow is contraindicated as the risks of surgery
outweigh the possible benefits39-41.
Flexor Tenosynovitis

Septic, suppurative, or pyogenic flexor
tenosynovitis (FTS) is a closed space infection of
the flexor tendon sheath. These infections are
associated with substantial morbidity, including
functional loss from stiffness, contracture,
adhesions, and even loss of the finger and/or limb if
not managed in a timely manner42-47. Even after
appropriate and expeditious treatment, residual
stiffness is commonplace. FTS makes up
approximately 10% of hand infections; some studies
report that the percentages are as high as 28.0% to
67.3%3,8,10,17,43. The most common pathogen is S.
aureus (35% to 75% of positive cultures), with the
rate of MRSA being 14.4% to 29%42,44-47. Other
common pathogens include Streptococcus species,
Pseudomonas species, and other gram-negative
organisms (these infections preferentially affect
immunocompromised patients)42,44-47.
On physical examination, patients may
exhibit Kanavel signs, including swelling of the
digit, tenderness along the flexor tendon sheath,
pain on passive extension of the finger, and a
resting flexed position of the finger (Fig. 2)42,44-47.
Only 54% of patients exhibit all 4 of these signs,
which may be less discernible in the thumb and the
fifth digit42,45,46. Studies attempting to validate the
cardinal signs yielded mixed results: most experts
agree that the combination of digital swelling and
tenderness along the tendon sheath is highly
indicative of FTS42,45,46. The detection of Kanavel
signs in children is inconsistent, which may cause
treatment delays45,46. Those with comorbidities may
not exhibit Kanavel signs as dramatically as
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otherwise healthy individuals42. The diagnosis of
FTS is clinical, and imaging is not needed.
Similarly, laboratory studies are nonspecific and are
typically negative in the acute phase of FTS.
Treatment depends on the extent and the
duration of symptoms. Healthy patients presenting
with mild symptoms for <48 hours can be treated
with empiric oral antibiotics (Table I) without
surgical debridement42,45. DiPasquale et al., in a 12patient case series, found that nonoperative therapy
(antibiotics, immobilization, elevation, and therapy)
in patients with early FTS was effective, with a
mean time to resolution of infective symptoms of 5
days (2 to 11 days)48. If symptoms worsen after
trialing nonsurgical management, then surgical
intervention is indicated. Surgical management
involves irrigation of the tendon sheath and
debridement. The 2 most common irrigation
techniques are open irrigation and closed irrigation
(continuous or intermittent). Open irrigation and
debridement is the technique of choice to facilitate
thorough drainage while also allowing for a
tenosynovectomy, if necessary42,45. Empiric
antibiotics (Table I) should be administered until
operative culture specimens identify the pathogen
and culture-specific antibiotics can be initiated.
Using cadaveric models for FTS, Ketonis et al.
found that S. aureus forms a biofilm on the flexor
tendon, and surgical drainage and irrigation is
inferior to mechanical debridement and local
antibiotic placement with corticosteroid
augmentation49. Based on these findings and in light
of the flexor tendon’s poor vascular supply,
consideration should be given for thorough
mechanical debridement of the flexor tendon and
subsequent local antibiotic placement.
Cellulitis

Cellulitis is an infection of the skin that
causes >600,000 hospitalizations every year in the
United States of America50. Involvement of the
hand is very common, with disruption of the skin
barrier being the most common cause5,51,52. S.
aureus is the most common pathogen, followed by
Streptococcus species5,11,15-20,50,51,53. The differential
diagnosis includes other infections such as
necrotizing fasciitis, varicella zoster, herpetic
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whitlow, and erythema migrans; inflammatory
conditions such as acute arthritis, gout, or bursitis;
and dermatologic conditions such as contact
dermatitis, hypersensitivity reaction, fixed drug
reaction, and venous stasis disease50.
Cellulitis typically presents as a unilateral
diffuse infection involving the dermis and
subcutaneous tissues (Fig. 3). Early-phase cellulitis
generally does not present with an abscess;
however, abscesses may form over time. Patients
typically report a history of pain, erythema, and
swelling of the symptomatic area50. Cellulitis is a
clinical diagnosis, and imaging is not required to
make the diagnosis; imaging studies can indicate
the extent of infection54. On computed tomography
(CT), cellulitis presents with soft-tissue thickening
and swelling, fat stranding, and enhancement on
contrast-enhanced imaging. Subcutaneous
emphysema without penetrating trauma suggests
necrotizing fasciitis50,54. Magnetic resonance
imaging (MRI) has been shown to be effective at
differentiating among cellulitis, necrotizing fasciitis,
and osteomyelitis, particularly in high-risk patient
populations54. Imaging should not be obtained in
patients with clear clinical evidence of cellulitis or
necrotizing fasciitis.
The treatment of cellulitis is nonsurgical and
is centered around antibiotic therapy against the
most likely organism, typically S. aureus or
Streptococcus species (Table I). Patients should be
reevaluated after 24 to 48 hours of antibiotic
therapy to assess clinical response55; most respond
to therapy within 5 to 10 days50. Antibiotics should
be continued for approximately 3 days after the
acute inflammation has subsided to ensure that the
infection has been treated adequately50.
Subcutaneous Abscess

A subcutaneous abscess is a purulent softtissue infection that generally follows a puncture
injury or wound5. The most common pathogen is S.
aureus5. The diagnosis is typically clinical, based
on physical examination findings and patient
history. A subcutaneous abscess generally presents
with a central fluctuant area surrounded by
cellulitis5. Because of the superficial nature of the
infection, imaging is generally not necessary.
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However, imaging in the form of ultrasonography
or MRI can be of value in equivocal cases28.
Treatment of a subcutaneous abscess consists of
incision and drainage, followed by empiric
antibiotic treatment (Table I) until wound culture
specimens specify the causative agent and culturespecific antibiotics can be administered5,56. Current
guidelines recommend antibiotic therapy for 7 to 14
days, with the final treatment duration depending on
the clinical response to the regimen7,23.
Deep Space Infections/Abscesses

Deep space infections of the hand occur in
the thenar space, the midpalmar space, the
hypothenar space, the space of Parona, the dorsal
subcutaneous and subaponeurotic spaces, and web
spaces2,4-9. Determination of the specific infected
location is essential as it drives surgical planning.
These infections make up 2% of all cases of hand
infection8,9. They are generally caused by direct
inoculation (i.e., penetrating injury) or contiguous
spread from nearby structures (i.e., septic FTS)2,5-7.
Presentations vary depending on the exact location
of the infection. The most common pathogens are
the normal skin flora, specifically Staphylococcus
and Streptococcus species2,3,8,10,11.
The diagnosis of deep space infections is
based on the physical examination in combination
with imaging. CT and ultrasound may indicate fluid
collections but have been shown to be inconsistent.
MRI has good sensitivity and specificity for deep
space infections and is very effective at
discriminating the location of the infection;
therefore, if expeditiously available, MRI should be
used to guide treatment4.
Typically, deep space infections present
with localized erythema, swelling, pain, and
possibly fluctuance (Fig. 4). Depending on the
specific location of the infection, additional signs
may be present on physical examination. For
example, thenar infections typically present with the
thumb abducted, pain on active extension and
opposition, and possible involvement of the first
web space2,4,5,8. In contrast, infections of the
midpalmar (or deep palmar) regions are bound by
the metacarpals and the palmar aponeurosis.
Therefore, these patients present with painful
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erythematous swelling on both the palmar and
dorsal surfaces of the hand, resulting in a loss of
concavity of the palm. They also experience
tenderness on active and passive movement of the
digits2,5,6,8. Hypothenar infections are infrequent and
present with inflammation and swelling of the ulnar
border of the hand. Patients will typically present
with the fifth digit abducted to maximize the
volume of the compartment6,8. Infection of the
space of Parona may spread to or from the radial or
ulnar bursae since they communicate with each
other. In general, swelling is diffuse, and patients
will present with pain on flexion of the digits and
wrist extension. The swelling also may compress
the median nerve, causing an acute carpal tunnel
syndrome2,5,8. Lastly, a web space infection also is
known as a “collar button abscess” because of its
hourglass configuration that spreads peripherally at
both the dorsal and palmar ends but remains narrow
in the middle while presenting with signs of both
palmar and dorsal inflammation. Typically, digits
on either side of the affected web are abducted to
maximize its volume2,4-6,8.
Treatment for all deep space infections of
the hand consists of incision and drainage of the
affected structures and areas. Empiric antibiotics
(Table I) should be administered until operative
culture specimens specify the causative agent and
culture-specific antibiotics can be initiated.
Animal Bites

The most common bite injuries of the hand
are from dogs, followed by those from cats57-60. Dog
and cat bites are the cause of 1% of all emergency
room visits in the United States59. Cat bites are
more common in women and the elderly, whereas
dog bites are more common among young children
(5 to 9 years old), most likely because of their small
size and lack of insight about provocative behavior
that could agitate a dog59. Generally, the animal is
known to the victim58.
Studies have shown that cat bites have a
higher risk of infection (up to 2 times greater) than
dog bites58-60. Bites resulting from dogs are
comparatively shallow and more crushing in
nature59-61. This is in contrast to cat bites, where
their sharp teeth result in lacerations with deeper
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penetration and direct tissue inoculation57-60,62,63.
Common complications resulting from animal bite
infections include cellulitis (Fig. 3), osteomyelitis,
septic arthritis, tenosynovitis, lymphangitis, and
local abscess57,59-63. Immunocompromised
individuals are at increased risk of the common
complications that are mentioned above in addition
to some uncommon complications: endocarditis,
meningitis, brain abscess, and sepsis59,60,63.
The most common pathogens in dog and cat
bites are Staphylococcus, Pasteurella, and
Streptococcus species57,59-63. However,
polymicrobial infections are common with all
animal bites.
Patients will typically present with
lacerations and/or puncture wounds to their hand
and a history that is noteworthy for an animal bite.
Specific clinical presentation depends on the animal
that bit the patient and the pathogen. Patients
presenting at >8 hours after the bite have
significantly higher rates of infection59,60. Animal
bite infections may progress rapidly due to direct
inoculation of the wound, with classic signs
including erythema, swelling, fluctuance, and
drainage (Fig. 3). Patients also may present with
local or proximal lymphadenitis and/or
lymphangitis.
Acquiring culture specimens from the site of
the animal bite is recommended because of their
polymicrobial nature. The management of animal
bites should always begin with empiric antibiotics.
For deep and/or fluctuant wounds, surgical
exploration, culture, and debridement may be
necessary. Prompt cleaning of the bite wound can
significantly reduce the risk of infection and rabies
transmission59,60.
Empiric antibiotics should adequately cover
the most likely pathogens: Staphylococcus,
Pasteurella, and Streptococcus species (Table I)57,5963. Empiric antibiotics should be administered until
culture specimens specify the causative agent and
culture-specific antibiotics can be initiated64. If the
rabies vaccination status of the animal is unknown,
one should consider administering the human
diploid vaccination series for rabies prophylaxis
and/or, depending on the exposure risk and the
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behavior of the animal, rabies immunoglobulin also
should be administered59,60.
Human Bites

Human bites are a relatively uncommon
cause of hand bite injuries, accounting for 2% of all
hand bite cases57,59. The most common
manifestation of these injuries is a closed-fist injury
due to fighting when the dorsal surface of the hand
contacts teeth, causing lacerations, commonly over
the metacarpophalangeal joints57. A variety of
anaerobes and aerobes may colonize a human bite
wound, with the most common pathogens being
those that form the natural flora of the mouth,
including Streptococcus pyogenes, S. aureus,
Eikenella corrodens, and Corynebacterium
species57,64,65.
Typically, human bite wounds and
infections present as isolated injuries, often centered
around the metacarpophalangeal joint from the teeth
lacerating the patient’s clenched hand57,64 (Fig. 5).
The wound and/or laceration may appear minor, but
the wound should be carefully examined as
penetration of deeper structures, including the
extensor mechanism and the metacarpophalangeal
joint capsule, is not uncommon57. Additionally,
radiographs are indicated to evaluate for fractures,
articular defects, or foreign bodies centered around
the bite wound and the associated
metacarpophalangeal joint57,64.
Human bite wound infections, even if
appropriately treated, may progress rapidly due to
direct inoculation of the site by oral flora64. Classic
signs of infection, including pain, erythema,
swelling, fluctuance, and drainage, may develop at
24 to 72 hours after the bite64. Patients also may
present with local lymphadenopathy, reducing the
range of motion of nearby joints64. Acquiring
culture specimens from the site of the bite wound is
recommended because of the polymicrobial nature
of bite wounds. The management of human bites
should always include empiric antibiotic
management (Table I). For deep and complex
human bite wounds, surgical intervention is
indicated to explore the wound, obtain culture
specimens, and debride and irrigate the wound.
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Fungal Infections

Fungal infections of the hand are rare and
typically present in immunocompromised
individuals66. These infections are categorized as
cutaneous, subcutaneous, deep, and systemic
infections2,5,67. Risk factors for fungal infections of
the hand include immunocompromised states,
chronic wounds, and sites of persistent
moisture8,41,66-68. Because of their low prevalence,
most of the data available regarding the
epidemiology, diagnosis, and treatment of fungal
infections are based on case reports, small series,
and expert opinion66. Unlike bacterial infections,
fungal infections of the hand tend to be less tender,
lack drainage, and are insidious.
Superficial/cutaneous fungal infections are
the most common fungal infection of the hand and
typically involve the glabrous skin (tinea corporis)
and the palms (tinea manuum), with the nails
(onychomycosis) being the most common
site2,5,41,67. Onychomycosis typically presents with
nail overgrowth/irregularities and surrounding
reddened and cracked skin2,67. Candida albicans
and other dermatophytes are the most common
cause of cutaneous and nail fungal infections41,67.
The causative pathogen can typically be identified
using fungal cultures and potassium hydroxide
(KOH) preparations2,5,41,67. The preferred treatment
for simple infections is topical antifungals (e.g.,
efinaconazole, amorolfine, tavaborole, or
ciclopirox)2,5,41. If initial therapy with a topical
antifungal fails to resolve the infection, then oral
antifungals (e.g., terbinafine, griseofulvin,
ketoconazole, fluconazole, or itraconazole) can be
initiated. Overall, nail-related fungal infections are
historically difficult to cure, with rates ranging from
57% to 80%, irrespective of the choice of antifungal
medication, and may require nail removal to
eradicate the fungal infection2,5,67.
A subcutaneous infection involves seeding
of the subcutaneous tissues by fungal spores. This
may result in a granulomatous infection with a
primary ulcerative lesion and secondary regional
lymphadenopathy. Sporotrichosis, also known as
“rose thorn disease,” is the most common
subcutaneous fungal infection of the hand. Other
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less common fungal pathogens include
histoplasmosis, blastomycosis, cryptococcus, and
coccidioidomycosis; the risk of these infections is
based on exposure history2,5,41,67. These organisms
can be identified via fungal cultures66. The preferred
antifungal treatment is echinocandins (e.g.,
caspofungin), triazoles (e.g., voriconazole,
itraconazole), or amphotericin B2,41,66,67.
Deep and systemic fungal infections are rare
and are caused by organisms that are either virulent
(histoplasmosis, blastomycosis,
coccidioidomycosis) or opportunistic
(mucormycosis, aspergillosis, Candida species).
These infections typically present in
immunocompromised patients and spread
hematogenously. Deep fungal infections will
require surgical intervention in the form of incision
and debridement with concurrent systemic
antifungals such as amphotericin B, itraconazole, or
ketoconazole2,5,41,66.
Overview

Patients presenting with hand infections may
be treated effectively by observing the principles of
prompt diagnosis, followed by judiciously
prescribed antibiotics and surgical management
when indicated.
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Fig. 1
Acute paronychia. Note the fluctuance and
erythema around the nail fold.
Fig. 2
Septic flexor tenosynovitis. Note the swelling,
erythema, and flexed posture of the finger. As this
is a long-standing case, there is also fluctuance.
Fig. 3
Cellulitis of the dorsum of the hand from a cat bite.
Note the erythema and edema in the subcutaneous
tissue.
Fig. 4
Deep space infection. Note the swelling, erythema,
and fluctuance emanating deep to the thenar
musculature.
Fig. 5
Human fight bite. Note the dorsal laceration and
swelling over the metacarpophalangeal joint. As
this is a late-presenting case, note the abduction of
the joint from the secondary septic joint
development and/or the collar button abscess
formation.
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TABLE I Initial Antibiotic Therapy Recommendations
Antibiotic Therapy
Infection
Cellulitis

Most Likely Organisms
Staphylococcus aureus
Streptococcus species

Intravenous
Vancomycin
Clindamycin

Felon

Staphylococcus aureus
Streptococcus species

Vancomycin
Clindamycin

Paronychia

Staphylococcus aureus
Streptococcus species
Pseudomonas species

Vancomycin
Clindamycin

Flexor tenosynovitis

Staphylococcus aureus
Streptococcus species

Vancomycin
Clindamycin

Subcutaneous abscess

Staphylococcus aureus
Streptococcus species

Vancomycin
Clindamycin

Deep space abscess

Staphylococcus aureus
Streptococcus species

Vancomycin
Clindamycin

Human bite

Staphylococcus species
Streptococcus species
Eikenella species
Corynebacterium species
Staphylococcus species
Streptococcus species
Pasteurella multocida
Herpes simplex virus

Ampicillin/sulbactam
Clindamycin
Ciprofloxacin

Oral
Doxycycline
Trimethoprim/sulfamethoxazole
Clindamycin
Doxycycline
Trimethoprim/sulfamethoxazole
Clindamycin
Doxycycline
Trimethoprim/sulfamethoxazole
Clindamycin
Ciprofloxacin
Doxycycline
Trimethoprim/sulfamethoxazole
Clindamycin
Ciprofloxacin
Doxycycline
Trimethoprim/sulfamethoxazole
Clindamycin
Doxycycline
Trimethoprim/sulfamethoxazole
Clindamycin
Amoxicillin/clavulanate
Clindamycin
Ciprofloxacin

Ampicillin/sulbactam
Clindamycin
Ciprofloxacin
Acyclovir

Amoxicillin/clavulanate
Clindamycin
Ciprofloxacin
Acyclovir

Animal bite
Herpetic whitlow
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